US · Healthcare

AgomAb Therapeutics NV American Depositary Shares (AGMB)

Biotechnology

AgomAb Therapeutics NV American Depositary Shares (AGMB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AGMB

P/E ratio

18.00

AgomAb Therapeutics NV American Depositary Shares (AGMB) — FAQ

What is AGMB's P/E ratio?

The price-to-earnings (P/E) ratio for AgomAb Therapeutics NV American Depositary Shares (AGMB) is 18.00 (data as of 2026-03-23).

Does AgomAb Therapeutics NV American Depositary Shares pay a dividend?

Dividend yield is not available in the current snapshot for AgomAb Therapeutics NV American Depositary Shares (AGMB). Check the MyAverix Finance app for the latest dividend data.

What sector is AgomAb Therapeutics NV American Depositary Shares in?

AgomAb Therapeutics NV American Depositary Shares (AGMB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AGMB listed on?

AGMB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)